https://scholars.lib.ntu.edu.tw/handle/123456789/446398
標題: | Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus | 作者: | Hsieh L.-E. Lin C.-N. Su B.-L. Jan T.-R. Chen C.-M. Wang C.-H. Lin D.-S. Lin C.-T. Chueh, Ling-Ling |
公開日期: | 2010 | 卷: | 88 | 期: | 1 | 起(迄)頁: | 25-30 | 來源出版物: | Antiviral Research | 摘要: | Feline infectious peritonitis (FIP) is a fatal disease in domestic and nondomestic felids caused by feline coronavirus (FCoV). Currently, no effective vaccine is available for the prevention of this disease. In searching for agents that may prove clinically effective against FCoV infection, 16 compounds were screened for their antiviral activity against a local FCoV strain in Felis catus whole fetus-4 cells. The results showed that Galanthus nivalis agglutinin (GNA) and nelfinavir effectively inhibited FCoV replication. When the amount of virus preinoculated into the test cells was increased to mimic the high viral load present in the target cells of FIP cats, GNA and nelfinavir by themselves lost their inhibitory effect. However, when the two agents were added together to FCoV-infected cells, a synergistic antiviral effect defined by complete blockage of viral replication was observed. These results suggest that the combined use of GNA and nelfinavir has therapeutic potential in the prophylaxis and treatment of cats with early-diagnosed FIP. ? 2010 Elsevier B.V. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/446398 | ISSN: | 0166-3542 | DOI: | 10.1016/j.antiviral.2010.06.010 | SDG/關鍵字: | aciclovir; agglutinin; atazanavir; efavirenz; emodin; idoxuridine; indinavir; lamivudine; lamivudine plus zidovudine; lopinavir plus ritonavir; nelfinavir; nevirapine; promazine; ribavirin; saquinavir; stavudine; animal cell; antiviral activity; article; cell line; cell strain fcwf 4; cell viability; concentration response; controlled study; Coronavirus; drug potentiation; drug screening; feline infectious peritonitis; fetus; Galanthus; galanthus nivalis; IC 50; nonhuman; priority journal; virus inhibition; virus load; virus replication; Animals; Antiviral Agents; Cats; Cells, Cultured; Coronavirus, Feline; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Feline Infectious Peritonitis; Fetus; Galanthus; Mannose-Binding Lectins; Microbial Sensitivity Tests; Nelfinavir; Plant Lectins; Virus Replication; Felidae; Feline coronavirus; Felis catus; Galanthus nivalis |
顯示於: | 臨床動物醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。